Study Protocol
Published on 03 May 2023
The challenges of a randomised placebo-controlled trial of CTO PCI vs. placebo with optimal medical therapy: The ORBITA-CTO pilot study design and protocol
in Coronary Artery Disease
![The challenges of a randomised placebo-controlled trial of CTO PCI vs. placebo with optimal medical therapy: The ORBITA-CTO pilot study design and protocol](https://www.frontiersin.org/files/myhome article library/1172763/1172763_Thumb_400.jpg)
- 3,183 views
- 2 citations
Study Protocol
Published on 03 May 2023
in Coronary Artery Disease
Review
Published on 02 May 2023
in Coronary Artery Disease
Clinical Trial
Published on 27 Apr 2023
in Coronary Artery Disease
Case Report
Published on 25 Apr 2023
in Coronary Artery Disease
Original Research
Published on 21 Apr 2023
in Coronary Artery Disease
Original Research
Published on 19 Apr 2023
in Coronary Artery Disease
Systematic Review
Published on 17 Apr 2023
in Coronary Artery Disease
Original Research
Published on 11 Apr 2023
in Coronary Artery Disease
Systematic Review
Published on 06 Apr 2023
in Coronary Artery Disease
Original Research
Published on 06 Apr 2023
in Coronary Artery Disease
Original Research
Published on 06 Apr 2023
in Coronary Artery Disease
Original Research
Published on 30 Mar 2023
in Coronary Artery Disease
Original Research
Published on 30 Mar 2023
in Coronary Artery Disease
Original Research
Published on 23 Mar 2023
in Coronary Artery Disease
Original Research
Published on 21 Mar 2023
in Coronary Artery Disease
Original Research
Published on 21 Mar 2023
in Coronary Artery Disease